Current treatment options for patients with initially unresectable isolated colorectal liver metastases

被引:10
|
作者
Kanat, Ozkan [1 ]
机构
[1] Uludag Univ, Fac Med, Dept Med Oncol, TR-16059 Gorukle, Bursa, Turkey
来源
WORLD JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 7卷 / 01期
关键词
Colorectal cancer; Conversion therapy; Liver metastases; Targeted therapy; Hepatic arterial infusion;
D O I
10.5306/wjco.v7.i1.9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The development of liver metastases is a common clinical entity in the clinical course of colorectal cancer. For patients with isolated liver involvement, surgical resection is the only treatment that can provide a chance of prolonged survival and cure. However, most of these patients are not initially eligible for the surgery. Selected patients with initially considered to have unresectable disease may become resectable after systemic (chemotherapy +/- biological therapy) and loco-regional treatment modalities including hepatic arterial infusion. Patients who have colorectal liver metastases ideally should be referred to a multidisciplinary cancer care team in order to identify the most optimal management approach.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 50 条
  • [1] Current treatment of colorectal liver metastases
    Tsalis K.
    Vasiliadis K.
    Christoforidis E.
    Vergos O.
    Angelopoulos S.
    Botsios D.
    Betsis D.
    Techniques in Coloproctology, 2004, 8 (Suppl 1) : S174 - S176
  • [2] Treatment options for liver metastases from colorectal cancer
    Lise, M
    Pilati, P
    Da Pian, P
    Mocellin, S
    Nitti, D
    Corozzino, S
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2003, 22 (04) : 149 - 156
  • [3] Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases
    Okuno, Masayuki
    Hatano, Etsuro
    Kasai, Yosuke
    Nishio, Takahiro
    Seo, Satoru
    Taura, Kojiro
    Yasuchika, Kentaro
    Nitta, Takashi
    Mori, Akira
    Okajima, Hideaki
    Kaido, Toshimi
    Hasegawa, Suguru
    Matsumoto, Shigemi
    Sakai, Yoshiharu
    Uemoto, Shinji
    SURGERY TODAY, 2016, 46 (06) : 721 - 728
  • [4] Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases
    Masayuki Okuno
    Etsuro Hatano
    Yosuke Kasai
    Takahiro Nishio
    Satoru Seo
    Kojiro Taura
    Kentaro Yasuchika
    Takashi Nitta
    Akira Mori
    Hideaki Okajima
    Toshimi Kaido
    Suguru Hasegawa
    Shigemi Matsumoto
    Yoshiharu Sakai
    Shinji Uemoto
    Surgery Today, 2016, 46 : 721 - 728
  • [5] The role of cetuximab in converting initially unresectable colorectal cancer liver metastases for resection
    Poston, G.
    Adam, R.
    Xu, J.
    Byrne, B.
    Esser, R.
    Malik, H.
    Wasan, H.
    Xu, J.
    EJSO, 2017, 43 (11): : 2001 - 2011
  • [6] Colorectal Liver Metastases: an Update on Palliative Treatment Options
    Konopke, Ralf
    Roth, Johanna
    Volk, Andreas
    Pistorius, Steffen
    Folprecht, Gunnar
    Zoephel, Klaus
    Schuetze, Christina
    Laniado, Michael
    Saeger, Hans-Detlev
    Kersting, Stephan
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2012, 21 (01) : 83 - 91
  • [7] United Kingdom criteria for liver transplantation in the setting of isolated unresectable colorectal liver metastases
    Murphy, Jamie
    Prasad, Raj
    Menon, Krishna
    COLORECTAL DISEASE, 2023, 25 (03) : 489 - 494
  • [8] Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases
    Junichiro Kawamura
    Takefumi Yazawa
    Kimiaki Sumida
    Yuya Kida
    Ryotaro Ogawa
    Masaki Tani
    Junya Kawasoe
    Michihiro Yamamoto
    Hideki Harada
    Hidekazu Yamamoto
    Masazumi Zaima
    World Journal of Surgical Oncology, 14
  • [9] A multiple microwave ablation strategy in patients with initially unresectable colorectal cancer liver metastases - A safety and feasibility study of a new concept
    Engstrand, J.
    Nilsson, H.
    Jansson, A.
    Isaksson, B.
    Freedman, J.
    Lundell, L.
    Jonas, E.
    EJSO, 2014, 40 (11): : 1488 - 1493
  • [10] Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)
    Folprecht, G.
    Gruenberger, T.
    Bechstein, W.
    Raab, H. -R.
    Weitz, J.
    Lordick, F.
    Hartmann, J. T.
    Stoehlmacher-Williams, J.
    Lang, H.
    Trarbach, T.
    Liersch, T.
    Ockert, D.
    Jaeger, D.
    Steger, U.
    Suedhoff, T.
    Rentsch, A.
    Koehne, C. -H.
    ANNALS OF ONCOLOGY, 2014, 25 (05) : 1018 - 1025